Skip to content

Evaluation of Tissue Oxygen Levels During Breast Reconstruction With a New Surgical Device

Prospective Non-randomized, Non-blinded, Convenience Sample to Evaluate the Surgical Imaging System

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03715270
Acronym
Presygen™
Enrollment
6
Registered
2018-10-23
Start date
2019-01-30
Completion date
2019-06-05
Last updated
2019-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perfusion; Complications

Brief summary

This study is designed to evaluate the information provided to the clinicians by the surgical imaging device. It is also to gain insight on the user interface and how user friendly it is to the clinician.

Detailed description

Over the last decade, objective ways of measuring tissue oxygen have been introduced into the medical arena and are being used more and more for assessing ischemic events in tissue. Handheld Doppler ultrasound, infrared thermography, polarized spectral imaging, laser Doppler perfusion imaging, and fluorescence imaging have all been used with some degree of success. However, only a few have gained universal acceptance. \[1\] Multispectral imaging (MSI) which uses near-infrared (NIR) light to measure tissue oxygen levels in superficial tissue is another method that has been successfully used to assess tissue flap health. The objective of this study is to conduct an evaluation of superficial tissue with Presygen™/si-1 in various patient types for surgical imaging during breast reconstruction. In addition, participating surgeons will complete a structured survey regarding their assessment of Presygen™/si-1 work station during the surgical procedure. Primary Goal: Evaluation of superficial tissue in various patient types for surgical imaging during breast reconstruction. Secondary Goal: Surgeon assessment of surgical work station during surgery through a prepared questionnaire.

Interventions

DEVICEImage surgical area

Image surgical area

Sponsors

Christie Medical Holdings, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Candidate for surgical intervention with breast reconstruction as part of the surgical plan * 22 years of age or older; * Able to understand and provide informed consent with HIPAA authorization. * Able to read and understand in English.

Exclusion criteria

* Subjects who might need a legally-authorized representative * Subjects who possess diminished mental capabilities * Conditions that preclude imaging (excessive scarring, tattoos in surgical field, Fitzpatrick Scale VI)

Design outcomes

Primary

MeasureTime frameDescription
Photographic, electronic and descriptive comparative analysis of superficial tissue oxygen saturation using Presygen™/si-1 for breast reconstruction subjects.24 hours.Quantitative measures of tissue oxygen saturation for discrete locations on superficial tissue.

Secondary

MeasureTime frameDescription
Quantitative survey providing surgeon assessment of work station during procedure.24 hourscompletion of basic questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026